Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2003
12/16/2003US6664077 DNA encoding ACPL
12/16/2003US6663873 Antigenic preparation for treatment or prevention of helicobacter infection
12/16/2003US6663872 Immune response
12/16/2003US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid
12/16/2003US6663868 Heat shock protein-based vaccines and immunotherapies
12/16/2003US6663867 Administering to a patient a hybrid protein comprising two different coexpressed amino acid sequences forming heterodimer, each comprising an amino acid sequence of tumor nacrosis factor binding protein and a subunit of hCG, FSG, LH
12/16/2003US6663865 Tumor necrosis factor antagonists and their use in endometriosis
12/16/2003US6663864 Crohn's disease, tumor necrosis factor, interleukins
12/16/2003US6663863 Method of inhibiting stenosis and restenosis
12/16/2003US6663862 Separation of Fc fragments and Fab fragments of a human IgG.
12/16/2003US6663861 Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins
12/16/2003CA2286879C Novel method for the production of anti-human antigen receptors and uses thereof
12/16/2003CA2134751C Monoclonal antibodies and their use
12/14/2003CA2430259A1 Vaccine
12/11/2003WO2003102584A2 Semaphorin-like proteins and methods of using same
12/11/2003WO2003102544A2 Assays for measuring matrix metalloproteinase activities
12/11/2003WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets
12/11/2003WO2003102199A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003WO2003102189A1 Allergen from mugwort pollen
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof
12/11/2003WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003WO2003102157A2 Synthetic antibody phage libraries
12/11/2003WO2003102136A2 Antibodies that specifically bind to neurokinin b
12/11/2003WO2003102132A2 Non-affinity purification of proteins
12/11/2003WO2003102030A1 Antibodies and their use for the modulation of taste sensation___
12/11/2003WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003WO2003102017A2 Anti-relp fusion antibodies, compositions, methods and uses
12/11/2003WO2003101497A1 Knockout mice and their use
12/11/2003WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003WO2003101394A2 Defensins: use as antiviral agents
12/11/2003WO2003101387A2 Globulin protein to lower cholesterol in humans
12/11/2003WO2003083077A3 Antibody libraries
12/11/2003WO2003074568A9 Individualized anti-cancer antibodies
12/11/2003WO2003070882A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and used thereof
12/11/2003WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
12/11/2003WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/11/2003WO2003060465A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/11/2003WO2003048306A3 Polycistronic expression of antibodies
12/11/2003WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy
12/11/2003WO2003029458A3 Method for producing protein libraries and for selecting proteins from said libraries
12/11/2003WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
12/11/2003WO2003009740A3 Methods for treating or preventing sclerotic disorders using cd2-binding agents
12/11/2003WO2003000727A3 Atopy
12/11/2003WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
12/11/2003WO2002075507B1 Anti-bacterial vaccine compositions
12/11/2003WO2002065943A3 Ocular tear growth factor-like protein
12/11/2003WO2002064788A3 Compositions and methods relating to lung specific genes and proteins
12/11/2003WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/11/2003WO1999024553A3 X-ray crystal comprising hiv-1 gp120
12/11/2003US20030229905 Generation of xenogeneic antibodies
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229454 Use of a computer to design a molecule
12/11/2003US20030229212 Using high-performance tangential-flow filtration (HPTFF) to isolate preferential polypeptides such as immunoadhesins; high throughput assay
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229207 Comprises immunoglobulin protein for preventing and treating transplant rejection, multiple sclerosis, autoimmune and graft-versus-host disease
12/11/2003US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030229021 Antiallergens
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030229005 Assays for measuring matrix metalloproteinase activities
12/11/2003US20030228667 Modulator of nuclear factor alpha beta for treating defects in immune responses, stress responses, inflammation or apoptosis
12/11/2003US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2003US20030228663 Polypeptides comprising light and variable chains domains for use in the treament of cancer
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228660 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/11/2003US20030228657 Methods for enhancing the translation and expression of recombinant proteins
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228649 Polypeptides for identifying fungicidally active compounds
12/11/2003US20030228641 Antibodies for enzymes of the omega-oxidation pathway and methods relating thereto
12/11/2003US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer
12/11/2003US20030228626 Product
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228590 Antibodies having specificity for nucleic acids
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228324 Peptide compositions and methods of producing and using same
12/11/2003US20030228323 Protein vaccine; culture product; genetic engineering
12/11/2003US20030228322 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
12/11/2003US20030228319 Antitumor agents, anticancer agents
12/11/2003US20030228318 PSCA: prostate stem cell antigen and uses thereof
12/11/2003US20030228316 Mitochondrial creatine kinase antibody
12/11/2003US20030228315 Generating antibodies; cardiovascular disorders
12/11/2003US20030228314 Aminopeptidase inhibitor
12/11/2003US20030228313 Method for improving body weight gain and feed conversion efficiency in animals
12/11/2003US20030228312 TNF receptor-specific antibodies
12/11/2003US20030228311 Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
12/11/2003US20030228310 Autoimmune diseases; administering interferon antibody
12/11/2003US20030228309 Anticancer agents; antiproliferative agents; induction apoptosis
12/11/2003US20030228307 Binding to platelet derived growth factor
12/11/2003US20030228306 Anti-CCR5 antibody
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228304 Induce immunology response; diagnosis kit
12/11/2003US20030228303 Antibodies specific for native PrPsc
12/11/2003US20030228302 Genetic engineering; determination, calibration polypeptide
12/11/2003US20030228291 Polynucleotide that encodes a polypeptide; binding specificity; useful in bone marrow transplantation and gene therapy
12/11/2003US20030228289 Universal chimera bank
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
1 ... 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 ... 1494